OTCMKTS:RLFTF

Relief Therapeutics Competitors

$0.23

-0.01 (-2.54 %)

(As of 06/18/2021 03:59 PM ET)

Add

Compare

Today's Range

$0.23

▼

$0.24

50-Day Range

$0.19

▼

$0.31

52-Week Range

$0.02

▼

$0.95

Volume2.25 million shs

Average Volume9.18 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Relief Therapeutics (OTCMKTS:RLFTF) Vs. DDXS, TNGN, ATTBF, AGNPF, LBTSF, and CBDC

Should you be buying RLFTF stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Relief Therapeutics, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), and Apotheca Biosciences (CBDC).

Relief Therapeutics vs. (DDXS) Stock

(DDXS) (OTCMKTS:DDXS) and Relief Therapeutics (OTCMKTS:RLFTF) are both health technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Profitability

This table compares (DDXS) and Relief Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
Relief Therapeutics	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and target prices for (DDXS) and Relief Therapeutics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
Relief Therapeutics	0	0	0	0	N/A

Valuation and Earnings

This table compares (DDXS) and Relief Therapeutics' top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
Relief Therapeutics	N/A	N/A	N/A	N/A	N/A

Relief Therapeutics vs. (TNGN) Stock

(TNGN) (OTCMKTS:TNGN) and Relief Therapeutics (OTCMKTS:RLFTF) are both health technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Profitability

This table compares (TNGN) and Relief Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(TNGN)	N/A	N/A	N/A
Relief Therapeutics	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and target prices for (TNGN) and Relief Therapeutics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(TNGN)	0	0	0	0	N/A
Relief Therapeutics	0	0	0	0	N/A

Valuation and Earnings

This table compares (TNGN) and Relief Therapeutics' top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(TNGN)	N/A	N/A	N/A	N/A	N/A
Relief Therapeutics	N/A	N/A	N/A	N/A	N/A

Relief Therapeutics vs. Abattis Bioceuticals Stock

Abattis Bioceuticals (OTCMKTS:ATTBF) and Relief Therapeutics (OTCMKTS:RLFTF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Profitability

This table compares Abattis Bioceuticals and Relief Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Abattis Bioceuticals	N/A	N/A	N/A
Relief Therapeutics	N/A	N/A	N/A

Valuation and Earnings

This table compares Abattis Bioceuticals and Relief Therapeutics' top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A
Relief Therapeutics	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Abattis Bioceuticals and Relief Therapeutics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abattis Bioceuticals	0	0	0	0	N/A
Relief Therapeutics	0	0	0	0	N/A

Relief Therapeutics vs. Algernon Pharmaceuticals Stock

Relief Therapeutics (OTCMKTS:RLFTF) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Profitability

This table compares Relief Therapeutics and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Relief Therapeutics	N/A	N/A	N/A
Algernon Pharmaceuticals	N/A	N/A	N/A

Valuation and Earnings

This table compares Relief Therapeutics and Algernon Pharmaceuticals' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Relief Therapeutics	N/A	N/A	N/A	N/A	N/A
Algernon Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent recommendations for Relief Therapeutics and Algernon Pharmaceuticals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Relief Therapeutics	0	0	0	0	N/A
Algernon Pharmaceuticals	0	0	0	0	N/A

Relief Therapeutics vs. Almirall Stock

Relief Therapeutics (OTCMKTS:RLFTF) and Almirall (OTCMKTS:LBTSF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Profitability

This table compares Relief Therapeutics and Almirall's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Relief Therapeutics	N/A	N/A	N/A
Almirall	N/A	N/A	N/A

Valuation and Earnings

This table compares Relief Therapeutics and Almirall's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Relief Therapeutics	N/A	N/A	N/A	N/A	N/A
Almirall	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent recommendations for Relief Therapeutics and Almirall, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Relief Therapeutics	0	0	0	0	N/A
Almirall	0	1	1	0	2.50

Summary

Almirall beats Relief Therapeutics on 1 of the 1 factors compared between the two stocks.

Relief Therapeutics vs. Apotheca Biosciences Stock

Relief Therapeutics (OTCMKTS:RLFTF) and Apotheca Biosciences (NASDAQ:CBDC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Profitability

This table compares Relief Therapeutics and Apotheca Biosciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Relief Therapeutics	N/A	N/A	N/A
Apotheca Biosciences	N/A	N/A	N/A

Valuation and Earnings

This table compares Relief Therapeutics and Apotheca Biosciences' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Relief Therapeutics	N/A	N/A	N/A	N/A	N/A
Apotheca Biosciences	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent recommendations for Relief Therapeutics and Apotheca Biosciences, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Relief Therapeutics	0	0	0	0	N/A
Apotheca Biosciences	0	0	0	0	N/A